Aquaporins in the Spinal Cord

Oklinski, Michal K.; Skowronski, Mariusz T.; Skowronska, Agnieszka; Rützler, Michael; Nørgaard, Kirsten; Nieland, John D.; Tae-Hwan Kwon; Nielsen, Søren
December 2016
International Journal of Molecular Sciences;Dec2016, Vol. 17 Issue 12, p2050
Academic Journal
Aquaporins (AQPs) are water channel proteins robustly expressed in the central nervous system (CNS). A number of previous studies described the cellular expression sites and investigated their major roles and function in the brain and spinal cord. Among thirteen different mammalian AQPs, AQP1 and AQP4 have been mainly studied in the CNS and evidence has been presented that they play important roles in the pathogenesis of CNS injury, edema and multiple diseases such as multiple sclerosis, neuromyelitis optica spectrum disorders, amyotrophic lateral sclerosis, glioblastoma multiforme, Alzheimer's disease and Parkinson's disease. The objective of this review is to highlight the current knowledge about AQPs in the spinal cord and their proposed roles in pathophysiology and pathogenesis related to spinal cord lesions and injury.


Related Articles

  • Magnetic resonance imaging in neuromyelitis optica. Tackley, George; Kuker, Wilhelm; Palace, Jacqueline // Multiple Sclerosis Journal;Aug2014, Vol. 20 Issue 9, p1153 

    Neuromyelitis optica (NMO), or Devic’s disease, is a rare demyelinating disorder of the central nervous system that has a predilection for the optic nerve and spinal cord. Magnetic resonance imaging (MRI) is required to diagnose NMO. Longitudinally extensive transverse myelitis is...

  • Aquaporin-4 Immuneglobulin G testing in 36 consecutive Jamaican patients with inflammatory central nervous system demyelinating disease. Sandy, Sherri; Pittock, Sean J.; Seemungal, Terence A. R.; Ali, Amza // Neurology International;2014, Vol. 6 Issue 3, p40 

    Epidemiological studies of neuromyelitis optica (NMO) in Jamaica are lacking. Here we reviewed the clinical records of 700 patients undergoing neurological evaluation at the Kingston Public Hospital, the largest tertiary institution in Jamaica over a 4 month period. We investigated the...

  • Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Sakakibara, Ryuji // Clinical Autonomic Research;Jun2019, Vol. 29 Issue 3, p313 

    Purpose: Multiple sclerosis (MS), neuromyelitis optica (NMO), and related disorders are major immune-mediated central nervous system diseases affecting the spinal cord. We reviewed the occurrence of neurogenic lower urinary tract dysfunction (NLUTD) in these categories of diseases. Methods: We...

  • Neuromyelitis Optica.  // Current Medical Literature: Multiple Sclerosis;2015, Vol. 7 Issue 3, p85 

    The article reviews a study on international views regarding the criteria for diagnosing disorders in neuromyelitis optica (NMO) called NMO spectrum disorders (NMOSD), published in "Neurology" in 2015.

  • White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study. Duan, Yunyun; Liu, Yaou; Liang, Peipeng; Jia, Xiuqin; Ye, Jing; Dong, Huiqing; Li, Kuncheng // Acta Radiologica;Jun2014, Vol. 55 Issue 5, p589 

    The article presents information on white matter atrophy in brain of neuromyelitis optica (NMO). Topics discussed include a voxel-based morphometry (VBM) study, Expanded Disability Status Scale (EDSS), and multiple sclerosis (MS). Also discussed are characterization of NMO, a severe form of...

  • Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Ringelstein, M; Metz, I; Ruprecht, K; Koch, A; Rappold, J; Ingwersen, J; Mathys, C; Jarius, S; Brück, W; Hartung, H-P; Paul, F; Aktas, O // Multiple Sclerosis Journal;Jun2014, Vol. 20 Issue 7, p882 

    Longitudinally extensive transverse myelitis is characteristic but not pathognomonic for neuromyelitis optica spectrum disorders (NMOSDs) and may mimic local tumors. In this retrospective study based on a cohort of 175 NMOSD patients we identified seven patients who initially presented with a...

  • Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. Juryńczyk, Maciej; Craner, Matthew; Palace, Jacqueline // Journal of Neurology, Neurosurgery & Psychiatry;Jan2015, Vol. 86 Issue 1, p20 

    Neuromyelitis optica (NMO) has long been considered as a variant of multiple sclerosis (MS) rather than a distinct disease. This concept changed with the discovery of serum antibodies (Ab) against aquaporin-4 (AQP4), which unequivocally differentiate NMO from MS. Patients who test positive for...

  • Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. Collongues, N; Marignier, R; Jacob, A; Leite, MI; Siva, A; Paul, F; Zephir, H; Akman-Demir, G; Elsone, L; Jarius, S; Papeix, C; Mutch, K; Saip, S; Wildemann, B; Kitley, J; Karabudak, R; Aktas, O; Kuscu, D; Altintas, A; Palace, J // Multiple Sclerosis Journal;Jul2014, Vol. 20 Issue 8, p1086 

    The article characterizes late onset of neuromyelitis optica (LONMO) and late onset of neuromyelitis optica spectrum disease (LONMOSD) and examines their predictive factors of disability and death. Both LONMO and LONMOSD are defined by an optic neuritis/longitudinally extensive transverse...

  • Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. Juryńczyk, Maciej; Weinshenker, Brian; Akman-Demir, Gulsen; Asgari, Nasrin; Barnes, David; Boggild, Mike; Chaudhuri, Abhijit; D'hooghe, Marie; Evangelou, Nikos; Geraldes, Ruth; Illes, Zsolt; Jacob, Anu; Kim, Ho; Kleiter, Ingo; Levy, Michael; Marignier, Romain; McGuigan, Christopher; Murray, Katy; Nakashima, Ichiro; Pandit, Lekha // Journal of Neurology;Jan2016, Vol. 263 Issue 1, p140 

    Distinguishing aquaporin-4 IgG(AQP4-IgG)-negative neuromyelitis optica spectrum disorders (NMOSD) from opticospinal predominant multiple sclerosis (MS) is a clinical challenge with important treatment implications. The objective of the study was to examine whether expert clinicians diagnose and...

  • The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica. Chen Cheng; Ying Jiang; Xiaodong Lu; Fu Gu; Zhuang Kang; Yongqiang Dai; Zhengqi Lu; Xueqiang Hu // BMC Neurology;10/21/2016, Vol. 16, p1 

    Background: Acute brainstem syndrome (ABS) may herald multiple sclerosis (MS), neuromyelitis optica (NMO), or occur as an isolated syndrome. The aquaporin 4 (AQP4)-specific serum autoantibody, NMO-IgG, is a biomarker for NMO. However, the role of anti-AQP4 antibody in the conversion of ABS to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics